Form D · Biotechnology
CONSTELLATION PHARMACEUTICALS INC
Cambridge, MA · CIK 0001434418
Offering snapshot reported Oct 8, 2019 · SEC filing
- Reported sold
- $65M Offering amount: $65M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2019 | Initial | $64,999,985 | No comparison | 11 | SEC filing |
| Apr 6, 2018 | Initial | $99,000,000 | No comparison | 30 | SEC filing |
| Sep 27, 2016 | Initial | $24,298,209 | No comparison | 17 | SEC filing |
| Dec 15, 2015 | Initial | $55,824,208 | No comparison | 22 | SEC filing |
| Aug 5, 2014 | Initial | $5,000,000 | No comparison | 8 | SEC filing |
| Jun 6, 2011 | Initial | $15,000,000 | No comparison | 7 | SEC filing |
| Jun 2, 2010 | Initial | $22,250,000 | No comparison | 9 | SEC filing |
| May 5, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-350552
Source: Form D, filed Oct 8, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James E. Audia | Director |
| Garen Bohlin | Executive |
| Scott Braunstein | Director |
| Michael R. Cooper | Executive |
| Keith Dionne | Director, Executive |
| Anthony Evnin | Director |
| David Goeddel | Director |
| Mark A. Goldsmith | Director |
| Edward E. Harlow, Jr. | Executive |
| Steven Hoerter | Director |
| Matthias Jaffe | Executive |
| Mark Levin | Director |
| Tom Maniatis | Director |
| Steven Paul | Director |
| Jigar Raythatha | Director, Executive |
| Emma Reeve | Executive |
| Kerry K. Reinertsen | Executive |
| Adrian Senderowicz | Executive |
| Peter Svennilson | Director |
| Robert Tepper | Director |
| Elizabeth G. Trehu | Director |
| Patrick Trojer | Executive |
| Karen Valentine | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
215 First Street Suite 200
Cambridge, MA, 02142
Cambridge, MA, 02142